Mosaic ImmunoEngineering Inc. (CPMV)

Mosaic ImmunoEngineering Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020	2020	2018
Market Capitalization	4	7	7	-	1	2
Market Cap Growth	-39.01%	4.62%	-	-	-65.00%	-80.00%
Enterprise Value	5	8	7	-0	-0	-0
PE Ratio	-	-3.01	-1.86	0	-0.87	-1.65
PB Ratio	-0.73	-1.47	-2.45	0	0.41	0.80
P/FCF Ratio	-7.19	-10.38	-10.08	-	-0.79	-1.52
P/OCF Ratio	-7.19	-10.38	-10.08	-	-0.79	-1.52
EV/EBITDA Ratio	-4.31	-3.58	-2.10	0.48	0.09	0.25
EV/EBIT Ratio	-	-	-	0.48	0.09	0.25
EV/FCF Ratio	-9.05	-11.84	-10.83	0.46	0.10	0.23
Debt / Equity Ratio	-0.23	-0.25	-0.26	0	0	0
Debt / EBITDA Ratio	-1.09	-0.54	-0.21	-	-	-
Debt / FCF Ratio	-2.30	-1.78	-1.08	-	-	-
Quick Ratio	0.06	0.06	0.10	0.46	6.85	27.11
Current Ratio	0.06	0.07	0.12	0.52	7.73	27.43
Interest Coverage	-14.58	-17.33	-22.86	0	-11.69	-4.94
Return on Equity (ROE)	22.35%	48.74%	131.63%	188.97%	-71.29%	-1.82%
Return on Assets (ROA)	-436.79%	-911.24%	-1367.18%	-174.41%	-62.84%	-1.76%
Return on Capital (ROIC)	37.86%	71.86%	177.40%	173.73%	-61.72%	-48.75%
Earnings Yield	-28.80%	-33.24%	-53.81%	-	-114.48%	-60.69%
FCF Yield	-13.03%	-9.63%	-9.92%	0.00%	-109.08%	-44.25%
Buyback Yield / Dilution	-0.01%	-7.79%	-742.14%	-	-	-
Total Shareholder Return	-0.01%	-7.79%	-742.14%	-	-	-

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.